Study: PET/MRI shows promise in restaging of prostate cancer

12/26/2012 | AuntMinnie.com (free registration)

Choline-PET/MRI identified more suspicious lesions compared with PET/CT in 31 patients with recurrent prostate cancer, according to a study presented at a radiology meeting. The study also found that PET/MRI performs comparably with PET/CT in identifying lymph node metastases and bone metastases. The findings indicate a fully diagnostic choline-PET/MRI protocol for restaging prostate cancer is well-tolerated and feasible in patients, researchers said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health